Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02719496
PHASE2

Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

The main objective of this study is to evaluate the efficacy of STW5 Iberogast, over a 28-day period, for the treatment of constipation in parkinsonian patients suffering from gastrointestinal disorders.

Key Details

Gender

All

Age Range

30 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2016-04

Completion Date

2018-04

Last Updated

2026-09-14

Healthy Volunteers

No

Interventions

DRUG

IBEROGAST

Locations (1)

Tiphaine Rouaud

Nantes, France